Second, we discovered that EFEMP1 could promote angiogenesis of endothelial cells to foster CNV development in the eye, providing new insights into the landscape of AMD pathophysiology and new targets for CNV treatment. This evidence concerns the gene EFEMP1 and age-related macular degeneration.